CONFIDENTIAL TREATMENT REQUESTEDConfidential Treatment Requested • July 11th, 2018 • Endocyte Inc • Pharmaceutical preparations
Portions of this Exhibit have been redacted pursuant to a request for confidential treatment under Rule 24b-2 of the General Rules and Regulations under the Securities Exchange Act of 1934, as amended. Omitted information, marked “[*]” in this Exhibit, has been filed separately with the Securities and Exchange Commission together with such request for confidential treatment.
